USE OF A MONOTERPENE TO TREAT OR PREVENT STRESS

• US 20110028549A1
• Filed: 05/09/2008
• Published: 02/03/2011
• Est. Priority Date: 05/11/2007
• Status: Abandoned Application

• Current Assignee: AISA Therapeutics
• Original Assignee: AISA Therapeutics
• Inventors: D'Alessio, Patrizia
• Application Number:
  US12/599,578
• Publication Number:
  US 20110028549A1
• Time in Patent Office: Days
• US Class Current: 514/557
• CPC Class Codes: A61K 31/015 carbocyclic
• CPC Class Codes: A61K 31/045 Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
• CPC Class Codes: A61K 31/19 Carboxylic acids, e.g. valproic acid salicylic acid A61K31/60
• CPC Class Codes: A61P 25/00 Drugs for disorders of the nervous system
• CPC Class Codes: A61P 25/18 Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
• CPC Class Codes: A61P 25/22 Anxiolytics

Abstract

The present invention relates to the use of a monoterpene for the prevention, alleviation or treatment of a pathological or non-pathological stress condition of an individual.

Claims

1. A method for preventing or alleviating a stress condition in an individual comprising administering an effective amount of a monoterpene to the individual in need thereof.

3. The method according to claim 1, the stress condition being a non-pathological stress condition.

4. The method according to claim 1 or 2, the individual being selected from the group consisting of a human, a pet, a laboratory animal and a farm animal.

5. The method according to claim 1 or 2, the individual being a cat or a dog.

6. The method according to claim 1 or 2, the monoterpene being limonene, one of its metabolites or a mixture thereof.

7. The method according to claim 1 or 2, the monoterpene being perillic alcohol or perillic acid.

8. The method according to claim 3, wherein the non-pathological stress condition is due to force-feeding in ducks or geese.

9. The method according to claim 3, wherein the non-pathological stress condition is due to carriage in horses.

10. The method according to claim 3, wherein the non-pathological stress condition is due to an exam in human.

2. A method for treating a pathological stress condition in an individual comprising administering a therapeutically effective amount of a monoterpene to the individual in need thereof.